A novel flow cytometric approach to distinguish circulating endothelial cells from endothelial microparticles: Relevance for the evaluation of endothelial dysfunction

Journal of Immunological Methods

Volumn 380, Issue 1-2, 2012, Pages 16-22

  Lanuti, Paola ^a   Santilli, Francesca ^a   Marchisio, Marco ^a   Pierdomenico, Laura ^a   Vitacolonna, Ester ^a   Santavenere, Eugenio ^a   Iacone, Antonio ^b   Davì, Giovanni ^a   Romano, Mario ^a   Miscia, Sebastiano ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b Civil Hospital   (Italy)

Author keywords

Absolute count; Diabetes; Endothelial microparticles; Flow cytometry; Vascular endothelium

Indexed keywords

CD146 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; STEM CELL FACTOR RECEPTOR;

ARTICLE; BLOOD; CELL COUNT; CIRCULATING ENDOTHELIAL CELL; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ENDOTHELIAL DYSFUNCTION; ENDOTHELIAL MICROPARTICLE; ENDOTHELIUM CELL; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MALE; MITOCHONDRION; PHENOTYPE; PRIORITY JOURNAL;

AGED; ANTIGENS, CD146; ANTIGENS, CD34; ANTIGENS, CD45; CELL-DERIVED MICROPARTICLES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; ENDOTHELIAL CELLS; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MIDDLE AGED;

EID: 84861187376     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2012.03.007     Document Type: Article

References (45)

1. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2006, 29:S43.
2. Avogaro A., Toffolo G., Kiwanuka E., de Kreutzenberg S.V., Tessari P., Cobelli C. l-Arginine-nitric oxide kinetics in normal and type 2 diabetic subjects: a stable-labelled 15N arginine approach. Diabetes 2003, 52:795.
3. Banfi C., Brioschi M., Wait R., Begum S., Gianazza E., Pirillo A., Mussoni L., Tremoli E. Proteome of endothelial cell-derived procoagulant microparticles. Proteomics 2005, 5:4443.
4. Bardin N., Frances V., Lesaule G., Horschowski N., George F., Sampol J. Identification of the S-Endo 1 endothelial-associated antigen. Biochem. Biophys. Res. Commun. 1996, 218:210.
5. Baumgarth N., Roederer M. A practical approach to multicolor flow cytometry for immunophenotyping. J. Immunol. Methods 2000, 243:77.
6. Bernard S., Loffroy R., Sérusclat A., Boussel L., Bonnefoy E., Thévenon C., Rabilloud M., Revel D., Moulin P., Douek P. Increased levels of endothelial microparticles CD144 (VE-cadherin) positives in type 2 diabetic patients with coronary noncalcified plaques evaluated by multidetector computed tomography (MDCT). Atherosclerosis 2009, 203:429.
7. Bertolini F., Shaked Y., Mancuso P., Kerbel R.S. The multifaceted circulating endothelial cell in cancer: towards marker and target identification. Nat. Rev. Cancer 2006, 6:835.
8. Blann A.D., Woywodt A., Bertolini F., Bull T.M., Buyon J.P., Clancy R.M., Haubitz M., Hebbel R.P., Lip G.Y., Mancuso P., Sampol J., Solovey A., Dignat-George F. Circulating endothelial cells. Biomarker of vascular disease. Thromb. Haemost. 2005, 93:228.
9. Boga C., Kozanoglu I., Ozdogu H., Sozer O., Sezgin N., Bakar C. Alteration of circulating endothelial cells after apheresis in patients with sickle cell disease: a potential clue for restoration of pathophysiology. Transfus. Apher. Sci. 2010, 43:273.
10. Boilard E., Nigrovic P.A., Larabee K., Watts G.F., Coblyn J.S., Weinblatt M.E., Massarotti E.M., Remold-O'Donnell E., Farndale R.W., Ware J., Lee D.M. Platelets amplify inflammation in arthritis via collagen-dependent microparticle production. Science 2010, 327:580.
11. Bull T.M., Golpon H., Hebbel R.P., Solovey A., Cool C.D., Tuder R.M., Geraci M.W., Voelkel N.F. Circulating endothelial cells in pulmonary hypertension. Thromb. Haemost. 2003, 90:698.
12. Dignat-George F., Boulanger C.M. The many faces of endothelial microparticles. Arterioscler. Thromb. Vasc. Biol. 2011, 31:27.
13. Dursun I., Düsünsel R., Poyrazoglu H.M., Gunduz Z., Patiroglu T., Ulger H., Gurgoze M.K. Circulating endothelial microparticles in children with Henoch-Schonlein purpura; preliminary results. Rheumatol. Int. 2010, 10.1007/s00296-010-1528-9.
14. Elsha M.F., Khan S.S., Raghavachar N., Takahashi Y., Barb J., Bailey J.J., Munson P.J., Solomon M.A., Danner R.L., McCoy J.P. A unique population of effector memory lymphocytes identified by CD146 having a distinct immunophenotypic and genomic profile. BMC Immunol. 2007, 8:29.
15. George F., Brouqui P., Boffa M.C., Mutin M., Drancourt M., Brisson C., Raoult D., Sampol J. Demonstration of Rickettsia conorii-induced endothelial injury in vivo by measuring circulating endothelial cells, thrombomodulin, and von Willebrand factor in patients with Mediterranean spotted fever. Blood 1993, 82:2109.
16. György B., Szabó T.G., Pásztói M., Pál Z., Misják P., Aradi B., László V., Pállinger E., Pap E., Kittel A., Nagy G., Falus A., Buzás E.I. Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell. Mol. Life Sci. 2011, 68:2667.
17. Hill J.M., Zalos G., Halcox J.P., Schenke W.H., Waclawiw M.A., Quyyumi A.A., Finkel T. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N. Engl. J. Med. 2003, 348:593.
18. Hristov M., Schmitz S., Schuhmann C., Leyendecker T., von Hundelshausen P., Krötz F., Sohn H.Y., Nauwelaers F.A., Weber C. An optimized flow cytometry protocol for analysis of angiogenic monocytes and endothelial progenitor cells in peripheral blood. Cytom. A 2009, 75:848.
19. Jacquez N., Vimond N., Conforti R., Griscelli F., Lecluse Y., Laplanche A., Malka D., Vielh P., Farace F. Quantification of circulating mature endothelial cells using a whole blood four-color flow cytometric assey. J. Immunol. Methods 2008, 337:132.
20. Jaumdally R.J., Lip G.Y., Patel J.V., MacFadyen R.J., Varma C. Effects of coronary artery disease and percutaneous intervention on the cardiac metabolism of nonesterified fatty acids and insulin: implications of diabetes mellitus. J. Intern. Med. 2009, 265:689.
21. Jung K.H., Chu K., Lee S.T., Bahn J.J., Kim J.H., Kim M., Lee S.K., Roh J.K. Risk of macrovascular complications in type 2 diabetes mellitus: endothelial microparticle profiles. Cerebrovasc. Dis. 2011, 31:485.
22. Khan S.S., Solomon M.A., McCoy J.P. Detection of circulating endothelial cells and endothelial progenitor cells by flow cytometry. Cytom. B Clin. Cytom. 2005, 64:1.
23. Kim I., Yilmaz O.H., Morrison S.J. CD144 (VE-cadherin) is transiently expressed by fetal liver hematopoietic stem cells. Blood 2005, 106:903.
24. Koga H., Sugiyama S., Kugiyama K., Watanabe K., Fukushima H., Tanaka T., Sakamoto T., Yoshimura M., Jinnouchi H., Ogawa H. Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease. J. Am. Coll. Cardiol. 2005, 45:1622.
25. Leroyer A.S., Rautou P.E., Silvestre J.S., Castier Y., Lesèche G., Devue C., Duriez M., Brandes R.P., Lutgens E., Tedgui A., Boulanger C.M. CD40 ligand+ microparticles from human atherosclerotic plaques stimulate endothelial proliferation and angiogenesis a potential mechanism for intraplaque neovascularization. J. Am. Coll. Cardiol. 2008, 52:1302.
26. Maecker H.T., Trotter J. Flow cytometry controls, instrument setup, and the determination of positivity. Cytom. A 2006, 69:1037.
27. Masouleh B.K., Baraniskin A., Schmiegel W., Schroers R. Quantification of circulating endothelial progenitor cells in human peripheral blood: establishing a reliable flow cytometry protocol. J. Immunol. Methods 2010, 357:38.
28. Morel O., Toti F., Hugel B., Freyssinet J.M. Cellular microparticles: a disseminated storage pool of bioactive vascular effectors. Curr. Opin. Hematol. 2004, 11:156.
29. Nomura S. Statin and endothelial cell-derived microparticles. Thromb. Haemost. 2008, 100:377.
30. Ozdogu H., Sozer O., Boga C., Kozanoglu L., Maytalman E., Guzey M. Flow cytometric evaluation of circulating endothelial cells: a new protocol for identifying endothelial cells at several stages of differentiation. Am. J. Hematol. 2007, 82:706.
31. Peichev M., Naiyer A.J., Pereira D., Zhu Z., Lane W.J., Williams M., Oz M.C., Hicklin D.J., Witte L., Moore M.A., Raffi S. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 2000, 95:952.
32. Petzelbauer P., Halama T., Gröger M. Endothelial adherents junctions. J. Invest. Dermatol. Symp. Proc. 2000, 5:10.
33. Pignone M., Alberts M.J., Colwell J.A., Cushman M., Inzucchi S.E., Mukherjee D., Rosenson R.S., Williams C.D., Wilson P.W., Kirkman M.S. Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation. Diabetes Care 2010, 33:1395. American Diabetes Association, American Heart AssociationAmerican Heart Association, American College of Cardiology FoundationAmerican College of Cardiology Foundation.
34. Prontera C., Martelli N., Evangelista V., D'Urbano E., Manarini S., Recchiuti A., Dragani A., Passeri C., Davì G., Romano M. Homocysteine modulates the CD40/CD40L system. J. Am. Coll. Cardiol. 2007, 49:2182.
35. Rafii S. Circulating endothelial precursors: mystery, reality, and promise. J. Clin. Invest. 2000, 105:17.
36. Roederer M. Spectral compensation for flow cytometry: visualization artifacts, limitations, and caveats. Cytometry 2001, 45:194.
37. Sabatier F., Darmon P., Hugel B., Combes V., Sanmarco M., Velut J.G., Arnoux D., Charpiot P., Freyssinet J.M., Oliver C., Sampol J., Dignat-George F. Type 1 and type 2 diabetic patients display different patterns of cellular microparticles. Diabetes 2002, 51:2840.
38. Shaffer R.G., Greene S., Arshi A., Supple G., Bantly A., Moore J.S., Mohler E.R. Flow cytometric measurement of circulating endothelial cells: the effect of age and peripheral arterial disease on baseline levels of mature and progenitor populations. Cytom. B Clin. Cytom. 2006, 70:56.
39. Sinning J.M., Losch J., Walenta K., Böhm M., Nickenig G., Werner N. Circulating CD31+/Annexin V+ microparticles correlate with cardiovascular outcomes. Eur. Heart J. 2011, 32:2034.
40. Smadja D.M., Gaussem P., Mauge L., Lacroix R., Gandrille S., Remones V., Peyrard S., Sabatier F., Bonnet D., Lévy M. Comparison of endothelial biomarkers according to reversibility of pulmonary hypertension secondary to congenital heart disease. Pediatr. Cardiol. 2010, 31:657.
41. Solovey A., Lin Y., Browne P., Choong S., Wayner E., Hebbel R.P. Circulating activated endothelial cells in sickle cell anemia. N. Engl. J. Med. 1997, 337:1584.
42. Strijbos M.H., Kraan J., den Bakker M.A., Lambrecht B.N., Sleijfer S., Gratama J.W. Cells meeting our immunophenotypic criteria of endothelial cells are large platelets. Cytom. B Clin. Cytom. 2007, 72:86.
43. Tramontano A.F., Lyubarova R., Tsiacos J., Palaia T., Deleon J.R., Ragolia L. Circulating endothelial microparticles in diabetes mellitus. Mediat. Inflamm. 2010, 10.1155/2010/250476.
44. Vasa M., Fichtlscherer S., Aicher A., Adler K., Urbich C., Martin H., Zeiher A.M., Dimmeler S. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ. Res. 2001, 89:E1.
45. World Medical Association declaration of Helsinki Recommendations guiding physicians in biomedical research involving human subjects. JAMA 1997, 277:925.